Lori Bluvas
Redwood City, CANPI 1922026590
Payments from drug & device makers
$2,490in general payments, 2019–2025
Across 118 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$702
- Mayne Pharma Commercial LLC$246
- Kaleo, Inc.$125
- Roche Diagnostics Corporation$124
- Bausch Health US, LLC$121
- Merck$114
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,45799%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $702 |
| Mayne Pharma Commercial LLC | 12 | $246 |
| Kaleo, Inc. | 6 | $125 |
| Roche Diagnostics Corporation | 6 | $124 |
| Bausch Health US, LLC | 6 | $121 |
| Merck | 7 | $114 |
| Pfizer | 4 | $88 |
| Urovant Sciences Inc | 3 | $85 |
| Hologic Sales And Service, LLC | 4 | $75 |
| Avion Pharmaceuticals | 6 | $74 |
| Johnson & Johnson | 2 | $71 |
| Sanofi Pasteur Inc. | 3 | $70 |
| Exact Sciences | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $59 |
| Lilly USA, LLC | 2 | $54 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| Neurocrine Biosciences, Inc. | 2 | $43 |
| Evofem Biosciences, Inc. | 2 | $38 |
| Sage Therapeutics, LLC | 1 | $35 |
| Bayer | 2 | $34 |
| AMAG Pharmaceuticals, Inc. | 2 | $33 |
| Seqirus USA Inc | 1 | $29 |
| Boston Scientific | 1 | $25 |
| Millicent US Inc | 1 | $23 |
| Myovant Sciences Inc. | 1 | $22 |
| Octapharma USA, Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Coloplast | 1 | $17 |
| Alk-abello, Inc | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.